The Parenteral Drug Association Connecting Drug Manufacturers, Glass Suppliers To Make Manufacturing Great

Published: May 26, 2017

BETHESDA, Md., May 25, 2017 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) is proud to announce a significant initiative to bring together executives, including CEOs and executive vice presidents, from biologic and pharmaceutical manufacturers with glass container and elastomeric closure suppliers to prepare industry for the complex products and manufacturing processes of the future. They aspire to achieve this through collective and collaborative continuous improvement projects to take today's world-class injectable medicine manufacturing to the next level.

Logo for Parenteral Drug Association. (PRNewsFoto/Parenteral Drug Association)

Their first initiative is to eliminate visible particles from parenteral products. Since December, a PDA task force, consisting of multidisciplinary members from biologic and pharmaceutical manufacturers and suppliers of glass container and elastomeric closures with over 1,000 years of experience combined, has been meeting with a focus on the entire supply chain from raw materials to finished product. This initiative represents an audacious goal, and will only succeed with all impacted parties working collaboratively toward the objective of eliminating visible particles.

PDA is also proud to announce a memorandum of understanding with the BioPhorum Operations Group who has worked with a team of professionals to improve the performance of rubber closures for parenteral products. The memorandum of understanding expands the collaboration and accelerates the development of best practices and standards, while striving to avoid the development of conflicting approaches.

Patients will be the key beneficiary from this effort to ensure quality medicines are delivered in a robust and reliable supply chain. The goals of the initiative epitomizes PDA's mission to advance pharmaceutical / biopharmaceutical manufacturing science and regulation so its members can better serve patients.

The initiative was made possible by PDA Chairman of the Board, Martin VanTrieste, who worked diligently to persuade over 40 executives representing over 30 companies to come to Bethesda, Maryland to join forces and work together to serve patients. These executives committed the necessary resources to staff the initiative with subject-matter experts consisting of manufacturing professionals, supply chain professionals, quality professionals, engineers, scientist and physicians.

About PDA Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,300 members worldwide. Go to to learn more.

About BioPhorum Operations Group

Since its inception in 2007, the BioPhorum Operations Group has been the open and trusted environment where commercially active biopharma companies come together to collaborate and develop operational best practices. With 31 biomanufacturers, and 21 supply partners working across 6 collaborations areas the group is practiced at mobilizing large cross industry teams to address complex operational challenges, improving performance and reducing patient risk.

Media Inquiries: Walt Morris, 301-656-5900, x. 148;

To view the original version on PR Newswire, visit:

SOURCE Parenteral Drug Association

Back to news